BLT Chemical Incident at Dunedin Site
Blis Technologies Limited: 81 Glasgow Street, South Dunedin 9012, PO Box 2208, Dunedin 9012, New Zealand
T:+64 3 474 0988 E: info@blis.co.nz W: www.blis.co.nz
12 July 2019
Chemical Incident at Dunedin Site
During a review of chemical stock at Blis Technologies’ (NZX:BLT) research and development
laboratory at its South Dunedin manufacturing site, staff noted early deterioration of a container
holding a small quantity of a substance used infrequently in basic research.
Action was taken by staff, in accordance with the company’s protocols, to contact experts to
understand the appropriate handling of the chemical and its disposal.
Fire and Emergency New Zealand has confirmed that the risk mitigation steps and actions were
appropriate.
Health and safety is a priority for the Board. In accordance with company protocols, a review of the
incident will be undertaken.
Ends
For further information, please contact:
Brian Watson
Chief Executive Officer
+64 27 705 9133
About Blis Technologies Ltd
Delivering proven health benefits through evidence-based, advanced probiotics
Blis is an NZX-listed manufacturer of advanced probiotic strains that go beyond the gut. Combining innovation
with evidence-based research and the highest quality production controls enables the delivery of probiotic
solutions for specific health targets including throat health, halitosis (bad breath), immune support and teeth and
gum health. BLIS products are sold throughout New Zealand and in Australia, Asia, Europe and the USA. More
information about Blis Technologies Ltd can be found at www.blis.co.nz.
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- PEB — Pacific Edge Limited: Cxbladder included in the NCCN Bladder Cancer Guidelines2019-07-15
“Company Announcement 15 July 2019 CXBLADDER INCLUDED IN THE LATEST NCCN BLADDER CANCER GUIDELINES IN THE USA Cancer diagnostics company, Pacific Edge (NZX: PEB), advises that Cxbladder has been included in the latest version of the National Comprehensive Cancer Network…”
- PEB — Pacific Edge Limited: Pacific Edge Reports Continued Growth in FY192019-05-28
“Company Announcement 29 May 2019 reimbursement and we expect to see a continued uplift in adoption and sales in FY20. We remain focused on the USA market which offers enormous potential for our company.” The Company’s key objectives for FY20 are as follows: • GLOBAL R…”
- EBO — EBOS Group Limited: EBOS Group Annual Report 20192019-09-24
“21 EBOS Group 2019 Annual Report Financials Corporate Governance Directors’ Interests & Disclosures Directory Business Overview New Zealand EBOS Group has significantly strengthened its New Zealand Healthcare business with the development of two major distribution centres…”